Levosimendan may prevent postoperative atrial fibrillation through anti-inflammatory and antioxidant modulation
- PMID: 19101169
- DOI: 10.1053/j.jvca.2008.09.022
Levosimendan may prevent postoperative atrial fibrillation through anti-inflammatory and antioxidant modulation
Comment on
-
A randomized trial evaluating different modalities of levosimendan administration in cardiac surgery patients with myocardial dysfunction.J Cardiothorac Vasc Anesth. 2008 Oct;22(5):699-705. doi: 10.1053/j.jvca.2008.02.019. Epub 2008 May 14. J Cardiothorac Vasc Anesth. 2008. Retraction in: J Cardiothorac Vasc Anesth. 2011 Oct;25(5):897. doi: 10.1053/j.jvca.2011.07.035. PMID: 18922426 Retracted. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
